Purified anti-mouse CD19 Antibody
- 产品名称：
- Purified anti-mouse CD19 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 115501
- 产品应用：
- 115501
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Mouse CD19-expressing K562 human erythroleukemia cells
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography.
- Concentration
- 0.5 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C.
- Application
-
FC - Quality tested
CyTOF? - Verified
IHC-F - Reported in the literature, not verified in house
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 1.0 ?g per million cells in 100 ?L volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Application Notes
Additional reported applications (for the relevant formats) include: immunofluorescence7.
- Application References
(PubMed link indicates BioLegend citation) -
- Shoham T, et al. 2003. J. Immunol. 171:4062. (FC)
- Goodyear CS, et al. 2004. J. Immunol. 172:2870. (FC)
- Kamimura D, et al. 2006. J. Immunol. 177:306. (FC)
- Andoniou CE, et al. 2005. Nat. Immunol. 6:1011. (FC)
- Lawson BR, et al. 2007. J. Immunol. 178:5366. (FC)
- Phan TG, et al. 2007. Nat. Immunol. 8:992. (FC)
- Hayashida K, et al. 2008. J. Biol. Chem. 283:19895. (IF) PubMed
- Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
- Bankoti J, et al. 2010. Toxicol. Sci. 115:422. (FC) PubMed
- Stadnisky MD, et al. 2011. Blood. 117:5133. (FC) PubMed
- Perlot T, et al. 2012. J. Immunol. 188:1201. (FC) PubMed
- Olive V, et al. 2013. Elife. 2:822. PubMed
- Miyai T, et al. 2014. PNAS. 111:11780. PubMed
- Product Citations
-
- Tersteegen A, et al. 2021. Infect Immun. 89:. PubMed
- Hu J, et al. 2019. Am J Transl Res. 3.043055556. PubMed
- Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
- Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
- Boal-Carvalho I, et al. 2020. EMBO Rep. 21:e50421. PubMed
- Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
- Mazor R, et al. 2018. Proc Natl Acad Sci U S A. 115:E733. PubMed
- Field CS, et al. 2018. Oncoimmunology. 7:e1376154. PubMed
- Carpenter SM, et al. 2017. PLoS Pathog. 13:e1006704. PubMed
- Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
- Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
- Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
- Niss Arfelt K, et al. 2017. Blood. 129:866. PubMed
- Taylor NA, et al. 2017. J Clin Invest. 127:3472. PubMed
- Hilligan KL, et al. 2020. Nat Commun. 11:5637. PubMed
- Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
- Yan J, et al. 2020. Cancer Immunol Res. 8:356. PubMed
- Chen L, et al. 2020. Front Immunol. 11:584458. PubMed
- Khan KA, et al. 2020. NPJ Breast Cancer. 6:29. PubMed
- He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
- Manni M, et al. 2018. Nat Immunol. 1.074305556. PubMed
- Ma W, et al. 2017. Sci Rep. . 10.1038/s41598-017-15661-6. PubMed
- Lim PJ, et al. 2019. Nat Metab. 0.402083333. PubMed
- McFarlane AJ, et al. 2017. J Allergy Clin Immunol. 140:1068. PubMed
- Borges TJ, et al. 2018. Nat Commun. 9:3482. PubMed
- Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
- You X, et al. 2022. Front Genet. 12:790990. PubMed
- Godoy-Calderón MJ, et al. 2018. Oncotarget. 8:11370. PubMed
- Nascimento DC, et al. 2017. Nat Commun. 8:14919. PubMed
- Shin J, et al. 2018. Diabetes. 67:1068. PubMed
- Majer O, et al. 2019. Nature. 575:366. PubMed
- Chen HW, et al. 2021. Biomedicines. 9:. PubMed
- Zelazowska MA, et al. 2020. Life Sci Alliance. :3. PubMed
- Rozanski C, et al. 2015. J Immunol. 194:4717. PubMed
- Oyarce K, et al. 2018. Front Immunol. 9:112. PubMed
- Rigo MM, et al. 2020. FEBS J. :. PubMed
- Gubin MM, et al. 2018. Cell. 175:1014. PubMed
- Parigi SM, et al. 2018. Sci Rep. 0.440277778. PubMed
- Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
- Goh W, et al. 2020. Cell Rep. 33:108285. PubMed
- Zhang MH, et al. 2020. Front Immunol. 11:560. PubMed
- Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
- Yang J, et al. 2019. Front Immunol. 2.492361111. PubMed
- Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
- Majri SS, et al. 2018. J Immunol. 200:110. PubMed
- Cui X, et al. 2017. J Immunol. 199:4066. PubMed
- Penninger T 2012. J Immunol. 188:1201. PubMed
- Korin B, et al. 2020. Sleep. :43. PubMed
- Zhu J et al. 2017. Cell stem cell. 20(3):374-384 . PubMed
- Hayashida K, et al. 2008. J Biol Chem. 283:19895. PubMed
- Stevens MY, et al. 2020. J Neuroinflammation. 0.899305556. PubMed
- Englezou PC, et al. 2018. Mol Ther Nucleic Acids. 12:118. PubMed
- Kikuchi K, et al. 2018. J Immunol. 201:635. PubMed
- Atif SM, et al. 2019. JCI Insight. 4:e125494. PubMed
- Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
- Khameneh HJ, et al. 2017. J Immunol. 198:196. PubMed
- Stadnisky M, et al. 2011. Blood. 117:5133. PubMed
- K?stele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
- Hwang JY, et al. 2020. Front Immunol. 11:570661. PubMed
- Sutiwisesak R, et al. 2020. PLoS Pathog. 16:e1009000. PubMed
- Chen YQ, et al. 2019. J Immunother Cancer. 0.415277778. PubMed
- RRID
- AB_313636 (BioLegend Cat. No. 115501) AB_313637 (BioLegend Cat. No. 115502)
- Structure
- Ig superfamily, associates with CD21 and CD81, 95 kD
- Distribution
-
Pro-B cells to mature B cells (during development), follicular dendritic cells
- Function
- Modulates B cell activation and differentiation
- Ligand/Receptor
- CD21, CD81, Leu-13
- Cell Type
- B cells, Dendritic cells
- Biology Area
- Costimulatory Molecules, Immunology
- Molecular Family
- CD Molecules
- Antigen References
-
1. Fearon DT. 1993. Curr. Opin. Immunol. 5:341.
2. Krop I, et al. 1996. Eur. J. Immunol. 26:238.
3. Krop I, et al. 1996. J. Immunol. 157:48.
4. Tedder TF, et al. 1994. Immunol. Today 15:437.
- Gene ID
- 12478 View all products for this Gene ID
- UniProt
- View information about CD19 on UniProt.org
